Yang Jian-Ling, Gu Shu-Ping, Chen Chen, Wang Zhu-Gang, Xu Yan, Fei Jian
Department of Life and Evironment Sciences, Shanghai Normal University, Shanghai, China.
Sheng Wu Gong Cheng Xue Bao. 2006 Nov;22(6):919-24.
The study of human new gene's function has become an increasingly active academic field basically relying on the gene knockout (KO) mouse. The construction of targeting vector economically and efficiently has turned into the key step to acquire a KO mouse because of the low efficiency of recombination with traditional constructed targeting vector. For study of the function of new gene-Resp18, we brought in a new DNA engineering platform-Red/ET recombination to construct Resp18 targeting vector. Red/ET recombineering differs from the conventional ways of vector construction (e.g., PCR, restriction enzyme digestion and ligation) and achieves genetic modification by acquisition, insertion, fusion or replacement of the target gene through small fragments mediated homologous recombination. Now Resp18 targeting vectors of three strategies were yielded successfully through two homologous recombination processes of retrieve and neo-targeting. Red/ET recombination has the advantage of getting longer homology regions without mutation, which makes it a new and reliable alternative to the construction of a targeting vector today.
基本上依靠基因敲除(KO)小鼠,人类新基因功能的研究已成为一个日益活跃的学术领域。由于传统构建的靶向载体重组效率低,经济高效地构建靶向载体已成为获得KO小鼠的关键步骤。为了研究新基因Resp18的功能,我们引入了一个新的DNA工程平台——Red/ET重组来构建Resp18靶向载体。Red/ET重组工程不同于传统的载体构建方法(如PCR、限制性酶切和连接),它通过小片段介导的同源重组对目标基因进行获取、插入、融合或替换来实现基因修饰。现在通过检索和新霉素靶向的两个同源重组过程成功产生了三种策略的Resp18靶向载体。Red/ET重组具有获得更长无突变同源区域的优势,这使其成为当今构建靶向载体的一种新的可靠选择。